Shawn M. Carter

Hemodiafiltration goes a step beyond hemodialysis to improve outcomes in kidney disease. But while the technology is becoming a global benchmark, it is not the norm for U.S. health care.That may change in the next year.

Peritoneal dialysis is safe for patients with autosomal dominant polycystic kidney disease, with no added risk associated with larger organ volumes, according to study data.“Autosomal dominant PKD (ADPKD) is the most prevalent genetic kidney disorder and the fourth leading cause of kidney failure, with 50% of patients reaching kidney failure by their sixth decade of life,” Fadi

Children in states with a high density of pediatric nephrologists may have better access to wait-listing and deceased donor kidney transplantation, according to study data. Researchers set out to examine how the size of the pediatric nephrologist workforce could impact wait-listing and transplant access for children with kidney failure. Using the United States Renal Data System, the study

DaVita has expanded its scope of care beyond dialysis by partnering with the American Diabetes Association, American Heart Association, YMCA and other organizations to address chronic kidney disease and related comorbidities. Jeffrey Giullian, MD, MBA, FASN, chief medical officer for DaVita and Healio

People with chronic kidney disease may benefit from physical activity, but many patients remain inactive, according to the findings in a study that assessed barriers to exercise. Physical activity can yield benefits for blood pressure, diabetes management, inflammation, functional capacity and quality of life. However, misconceptions persist among health care professionals, including concerns

Key takeaways: Mean albumin loss was significantly higher for patients undergoing expanded hemodialysis without affecting pre-dialysis serum albumin.

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients with kidney disease and type 2 diabetes, according to researchers.In January, the first GLP-1 receptor agonist, semaglutide (Ozempic, Novo Nordisk), was approved by the FDA for use by adults with type 2 diabetes and chronic kidney disease to reduce the risk for worsening CKD

Worldwide prevalence of kidney failure requiring dialysis nearly tripled since 1990 to reach 4.6 million cases in 2023, according to results of the Global Burden of Disease study 2023.Researchers reported differences in the number of diagnoses across regions, as well as between men and women. The analysis also found that type 2 diabetes and hypertension were the leading drivers of kidney failure

Prophylactic antibiotic use before tunneled cuffed catheter insertion was not linked to a lower rate of early hemodialysis catheter-related bloodstream infections, a study found.

Once you've opened an IRA, you should invest your IRA contributions. Make sure you understand the fees for and investments in your account.